121 related articles for article (PubMed ID: 37244359)
1. Having ypN0 may not be enough to abandon the Postmastectomy Radiotherapy (PMRT) in Her-2 positive patients.
Fayda M
Radiother Oncol; 2023 Aug; 185():109722. PubMed ID: 37244359
[No Abstract] [Full Text] [Related]
2. [The role of postmastectomy radiotherapy in clinical T1-3N1M0 breast cancer patients with pathological negative lymph nodes after neoadjuvant chemotherapy and mastectomy].
Rong QL; Wang SL; Tang Y; Jin J; Song YW; Wang WH; Liu YP; Fang H; Ren H; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):445-452. PubMed ID: 28635235
[No Abstract] [Full Text] [Related]
3. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
[TBL] [Abstract][Full Text] [Related]
4. Post-mastectomy radiation therapy in HER-2 positive breast cancer after primary systemic therapy: Pooled analysis of TRYPHAENA and NeoSphere trials.
Saifi O; Bachir B; Panoff J; Poortmans P; Zeidan YH
Radiother Oncol; 2023 Jul; 184():109668. PubMed ID: 37030399
[TBL] [Abstract][Full Text] [Related]
5. The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB.
Liu J; Mao K; Jiang S; Jiang W; Chen K; Kim BY; Liu Q; Jacobs LK
Oncotarget; 2016 Apr; 7(17):24848-59. PubMed ID: 26709538
[TBL] [Abstract][Full Text] [Related]
6. Postmastectomy radiotherapy in patients with T
Luo M; Jin Y; Xu C; Chen H; Zhang K; Chen Q; Jin C; Lu J; Wang J; Huang J; Deng H; Jin W; Zheng S; Chen Y; Zhou J
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9979-9990. PubMed ID: 37256383
[TBL] [Abstract][Full Text] [Related]
7. Indications for Postmastectomy Radiation After Neoadjuvant Chemotherapy in ypN0 and ypN1-3 Axillary Node-Positive Women.
Fowble B; Jairam AK; Wang F; Peled A; Alvarado M; Ewing C; Esserman L; Park C; Lazar A
Clin Breast Cancer; 2018 Feb; 18(1):e107-e113. PubMed ID: 28830795
[TBL] [Abstract][Full Text] [Related]
8. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
[No Abstract] [Full Text] [Related]
9. The role of different lymph node staging systems in predicting prognosis and determining indications for postmastectomy radiotherapy in patients with T1-T2pN1 breast carcinoma.
Kustić D; Klarica Gembić T; Grebić D; Petretić Majnarić S; Nekić J
Strahlenther Onkol; 2020 Nov; 196(11):1044-1054. PubMed ID: 32710122
[TBL] [Abstract][Full Text] [Related]
10. Nomogram predicting survival as a selection criterion for postmastectomy radiotherapy in patients with T1 to T2 breast cancer with 1 to 3 positive lymph nodes.
Tang Y; Zhang YJ; Zhang N; Shi M; Wen G; Cheng J; Wang HM; Liu M; Wang XH; Guo QS; Wu HF; Ma CY; Jin J; Liu YP; Song YW; Fang H; Ren H; Wang SL; Li YX
Cancer; 2020 Aug; 126 Suppl 16():3857-3866. PubMed ID: 32710662
[TBL] [Abstract][Full Text] [Related]
11. Postmastectomy radiotherapy: indications and implications.
Walsh SM; Lowery AJ; Prichard RS; McDermott EW; Evoy D; Geraghty J
Surgeon; 2014 Dec; 12(6):310-5. PubMed ID: 25037652
[TBL] [Abstract][Full Text] [Related]
12. The clinical value of adjuvant radiotherapy in patients with early stage breast cancer with 1 to 3 positive lymph nodes after mastectomy.
Wu SG; He ZY; Li FY; Wang JJ; Guo J; Lin Q; Guan XX
Chin J Cancer; 2010 Jul; 29(7):668-76. PubMed ID: 20591219
[TBL] [Abstract][Full Text] [Related]
13. Patterns of postmastectomy radiation therapy in clinically node-positive breast cancerpatients with pathologically negative lymph nodes after neoadjuvant chemotherapy.
Sayan M; Vergalasova I; George M; Kowzun M; Potdevin L; Kumar S; Haffty B; Ohri N
Turk J Med Sci; 2022 Apr; 52(2):279-285. PubMed ID: 36161617
[TBL] [Abstract][Full Text] [Related]
14. One size does not fit all: PMRT in ypN0 HER-2 positive breast cancer.
Saifi O; Zeidan YH
Radiother Oncol; 2023 Aug; 185():109725. PubMed ID: 37244361
[No Abstract] [Full Text] [Related]
15. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of a multidisciplinary team-led discussion in predicting postmastectomy radiotherapy.
Wilson M; Dordea M; Light A; Serra MP; Aspinall SR
Ann R Coll Surg Engl; 2015 Apr; 97(3):198-203. PubMed ID: 26263804
[TBL] [Abstract][Full Text] [Related]
17. Postmastectomy Radiation Therapy for Node-Negative Breast Cancer of 5 cm or Larger Tumors: A Multicenter Retrospective Analysis (KROG 20-03).
Kim K; Jung J; Kim H; Jung W; Shin KH; Chang JH; Kim SS; Park W; Chang JS; Kim YB; Ahn SJ; Lee IJ; Lee JH; Park HJ; Cha J; Kim J; Choi JH; Koo T; Kwon J; Kim JH; Kim MY; Park SH; Kim YJ
Cancer Res Treat; 2022 Apr; 54(2):497-504. PubMed ID: 34445845
[TBL] [Abstract][Full Text] [Related]
18. Is it beneficial for patients with pT1-2N1M0 breast cancer to receive postmastectomy radiotherapy? An analysis based on RecurIndex assay.
Zhang L; Zhou M; Liu Y; Du F; Tang J; Wang N; Song C; Geng C; Duan H
Int J Cancer; 2021 Nov; 149(10):1801-1808. PubMed ID: 34224580
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Breast Cancer Patients with T1-2 Tumors and 1-3 Positive Lymph Nodes Treated with or without Postmastectomy Radiation Therapy.
Gilmore RC; Sebai ME; Psoter KJ; Prasath V; Siotos C; Broderick KP; Jacobs LK; Harvey SC; Habibi M
Sci Rep; 2020 Jun; 10(1):9887. PubMed ID: 32555240
[TBL] [Abstract][Full Text] [Related]
20. Increased utilization of postmastectomy radiotherapy in the United States from 2003 to 2011 in patients with one to three tumor positive nodes.
Yao K; Liederbach E; Lutfi W; Wang CH; Hou N; Karrison T; Huo D
J Surg Oncol; 2015 Dec; 112(8):809-14. PubMed ID: 26486998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
